SCYNEXIS INC (SCYX)
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Address
1 EVERTRUST PLAZA
JERSEY CITY, NJ 07302-6548
Founded
1999
Number of Employees
29
Website
http://www.scynexis.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)